Radiation Therapy

Radiation Therapy
Dina Wakulchik from Indianapolis, Indiana, USA · CC BY 2.0 · source
Name	Radiation Therapy
Specialty	Oncology, Radiation Oncology

Radiation Therapy is a medical treatment that uses ionizing radiation to target pathological tissues, primarily neoplasms, by damaging cellular DNA and disrupting proliferative capacity. Developed through contributions from physicists, physicians, and engineers, it integrates technologies and institutions across clinical oncology, medical physics, and biomedical engineering to deliver precision care.

History

The origins trace to discoveries by Wilhelm Röntgen, Henri Becquerel, and Marie Curie, which prompted early therapeutic experiments at institutions such as Massachusetts General Hospital and Mayo Clinic in the late 19th and early 20th centuries. Pioneering clinical and technological advances involved figures and centers including Ernest Rutherford, George de Hevesy, Royal Marsden Hospital, and Johns Hopkins Hospital, leading to the adoption of orthovoltage and megavoltage machines developed by companies like Siemens and Varian Medical Systems. The mid-20th century saw integration with surgical oncology at places such as Memorial Sloan Kettering Cancer Center and innovation driven by research groups at CERN and national laboratories including Brookhaven National Laboratory. Landmark trials and cooperative groups such as the National Cancer Institute clinical networks and European Organisation for Research and Treatment of Cancer established evidence-based protocols, while regulatory milestones from agencies like the U.S. Food and Drug Administration shaped device approval and clinical practice.

Types and Techniques

Contemporary modalities range from external beam radiotherapy using linear accelerators developed by firms like Philips and Elekta to brachytherapy procedures performed at specialized centers such as Gustave Roussy and MD Anderson Cancer Center. Advanced external techniques include three-dimensional conformal radiotherapy (3D-CRT) pioneered in academic centers like Stanford University, intensity-modulated radiotherapy (IMRT) advanced at institutions like University of Florida, volumetric modulated arc therapy (VMAT) commercialized by vendors including Elekta, and stereotactic radiosurgery/stereotactic body radiotherapy (SRS/SBRT) refined at University of Pittsburgh Medical Center and Karolinska Institute. Particle therapies—proton therapy and carbon-ion therapy—have been implemented at specialist facilities such as Loma Linda University Medical Center and HIMAC in Japan, influenced by accelerator physics groups at CERN and Brookhaven National Laboratory. Image-guided radiotherapy (IGRT) integrates modalities from General Electric, Siemens Healthineers, and Canon Medical Systems with treatment planning systems developed by software teams at Elekta and Varian Medical Systems.

Clinical Indications and Treatment Planning

Indications encompass malignancies treated at referral centers like Royal Marsden Hospital, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center for sites including head and neck, thoracic, gastrointestinal, genitourinary, gynecologic, and central nervous system tumors. Multidisciplinary tumor boards at hospitals such as Mayo Clinic coordinate radiotherapy with surgical oncology teams from Cleveland Clinic and medical oncology services tied to groups like European Society for Medical Oncology and American Society of Clinical Oncology. Treatment planning uses contouring atlases from collaborative groups including Radiation Therapy Oncology Group and dose-prescription conventions influenced by trials from National Comprehensive Cancer Network committees. Planning workflows employ Monte Carlo and collapsed-cone algorithms created by research teams at Massachusetts Institute of Technology, University of Cambridge, and University of California, San Francisco to optimize therapeutic ratio and spare organs at risk defined by consensus panels from International Atomic Energy Agency and professional societies.

Side Effects and Complications

Acute and late effects documented in clinical series from institutions such as MD Anderson Cancer Center and registries managed by SEER Program include dermatitis, mucositis, pneumonitis, enteritis, cystitis, fibrosis, and radiation-induced secondary malignancies reported in cohort studies from Johns Hopkins Hospital and Karolinska Institute. Management algorithms reference guidelines produced by American Society for Radiation Oncology and supportive-care protocols developed at St. Jude Children's Research Hospital and pediatric oncology consortia like Children's Oncology Group. Complication mitigation strategies incorporate technologies and techniques trialed at Stanford University, University College London Hospitals, and University of Toronto including adaptive planning, motion management from groups at Massachusetts General Hospital, and prophylactic interventions evaluated in randomized trials sponsored by bodies such as National Cancer Institute.

Safety, Dosimetry, and Quality Assurance

Dosimetry standards and calibration traceability are governed by national metrology institutes such as National Physical Laboratory and organizations including International Commission on Radiation Units and Measurements and International Atomic Energy Agency, with code-of-practice documents used by medical physics groups at The Royal Marsden Hospital and Peter MacCallum Cancer Centre. Quality assurance programs implemented at centers like Dana-Farber Cancer Institute and Johns Hopkins Hospital incorporate end-to-end testing, film and array-based phantom measurements developed by research labs at Sandia National Laboratories and National Institute of Standards and Technology, and incident reporting frameworks modeled after systems at World Health Organization. Radiation protection principles from International Commission on Radiological Protection guide shielding design in facilities planned by engineering firms collaborating with Lawrence Berkeley National Laboratory and clinical teams at University of Pennsylvania.

Advances and Research

Active research programs at universities and institutes such as Harvard Medical School, University of Oxford, Massachusetts Institute of Technology, RIKEN, and Institut Curie explore radioimmunotherapy combinations, radiogenomics, and artificial intelligence-driven planning from labs at Google DeepMind and IBM Research. Clinical trials run by cooperative groups including European Organisation for Research and Treatment of Cancer and National Cancer Institute investigate hypofractionation, proton/carbon-ion comparative outcomes at centers like Proton Therapy Center Czech Republic and National Institute of Radiological Sciences, and biomarkers validated in consortia involving Wellcome Trust and Bill & Melinda Gates Foundation. Translational initiatives integrate molecular imaging from National Institutes of Health programs and theranostics developed at Memorial Sloan Kettering Cancer Center and Mayo Clinic, aiming to personalize dose painting, reduce toxicity, and improve survival.

Category:Oncology